Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Leukemia
Leukemia is a term for cancers of the blood cells. Leukemia starts in blood-forming tissues such as the bone marrow. Your bone marrow makes the cells which will develop into white blood cells, red blood cells, and platelets. Each type of cell has a different job:
- White blood cells help your body fight infection
- Red blood cells deliver oxygen from your lungs to your tissues and organs
- Platelets help form clots to stop bleeding
When you have leukemia, your bone marrow makes large numbers of abnormal cells. This problem most often happens with white blood cells. These abnormal cells build up in your bone marrow and blood. They crowd out the healthy blood cells and make it hard for your cells and blood to do their work.
There are different types of leukemia. Which type of leukemia you have depends on the type of blood cell that becomes cancer and whether it grows quickly or slowly.
The type of blood cell could be:
- Lymphocytes, a type of white blood cell
- Myeloid cells, immature cells that become white blood cells, red blood cells, or platelets
The different types can grow quickly or slowly:
- Acute leukemia is fast growing. It usually gets worse quickly if it's not treated.
- Chronic leukemia is slow growing. It usually gets worse over a longer period of time.
The main types of leukemia are:
- Acute lymphocytic leukemia (ALL), which is the most common type of cancer in children. It can also affect adults.
- Acute myeloid leukemia (AML), which is more common in older adults but can also affect children
- Chronic lymphocytic leukemia (CLL), which is one of the most common types of leukemia in adults. It often occurs during or after middle age.
- Chronic myeloid leukemia (CML), which usually occurs in adults during or after middle age
Leukemia happens when there are changes in the genetic material (DNA) in bone marrow cells. The cause of these genetic changes is unknown.
For the specific types, there are different factors which can raise your risk of getting that type. Overall, your risk of leukemia goes up as you age. It is most common over age 60.
Some of the symptoms of leukemia may include:
- Feeling tired
- Fever or night sweats
- Easy bruising or bleeding
- Weight loss or loss of appetite
- Petechiae, which are tiny red dots under the skin. They are caused by bleeding.
Other leukemia symptoms can be different from type to type. Chromic leukemia may not cause symptoms at first.
Your health care provider may use many tools to diagnose leukemia:
- A physical exam
- A medical history
- Blood tests, such as a complete blood count (CBC)
- Bone marrow tests. There are two main types - bone marrow aspiration and bone marrow biopsy. Both tests involve removing a sample of bone marrow and bone. The samples are sent to a lab for testing.
- Genetic tests to look for gene and chromosome changes
Once the provider makes a diagnosis, there may be additional tests to see whether the cancer has spread. These include imaging tests and a lumbar puncture, which is a procedure to collect and test cerebrospinal fluid (CSF).
The treatments for leukemia depend on which type you have, how severe the leukemia is, your age, your overall health, and other factors. Some possible treatments might include:
- Chemotherapy
- Radiation therapy
- Chemotherapy with stem cell transplant
- Targeted therapy, which uses drugs or other substances that attack specific cancer cells with less harm to normal cells
It sits within Cancers and Blood, Heart and Circulation.
The lead U.S. institute for this subject is the National Cancer Institute.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Leukemia
9,677 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous LeukemiaNational Cancer Institute (NCI)
- Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic LeukemiaChildren's Oncology Group
- Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or VenetoclaxNational Heart, Lung, and Blood Institute (NHLBI)
- Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic SyndromeChildren's Oncology Group
- Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)
- Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic MalignanciesNational Cancer Institute (NCI)
Research already completed
- CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)M.D. Anderson Cancer Center
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
Diagnosis and Tests
- Beta 2 Microglobulin (B2M) Tumor Marker TestNational Library of Medicine
- Blood Count Tests: MedlinePlus Health TopicNational Library of Medicine
- Blood TestsNational Heart, Lung, and Blood Institute
- Bone Marrow TestsNational Library of Medicine
- Lab and Imaging TestsBlood Cancer United
- Tests for Chronic Myelomonocytic Leukemia (CMML)American Cancer Society
- TP53 Genetic TestNational Library of Medicine
Treatments and Therapies
- Blood TransfusionBlood Cancer United
- Bone Marrow Transplantation: MedlinePlus Health TopicNational Library of Medicine
- Choosing a Blood Cancer Specialist or a Treatment CenterBlood Cancer United
- Chronic Myeloproliferative Neoplasms TreatmentNational Cancer Institute
- Drugs Approved for LeukemiaNational Cancer Institute
- General Approach to Treating Chronic Myelomonocytic Leukemia (CMML)American Cancer Society
- ImmunotherapyBlood Cancer United
- Integrative Medicine and Complementary TherapiesBlood Cancer United
Related Issues
- Electromagnetic Fields and CancerNational Cancer Institute
Statistics and Research
- Advances in Leukemia ResearchNational Cancer Institute
- Blood Cancer Facts and StatisticsBlood Cancer United
- Cancer Statistics: LeukemiaNational Cancer Institute
Clinical Trials
- Blood Cancer UnitedBlood Cancer United
- ClinicalTrials.gov: LeukemiaNational Institutes of Health
- ClinicalTrials.gov: Leukemia, Hairy CellNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Leukemia. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Leukemia, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.